跳至主要内容
临床试验/JPRN-C000000246
JPRN-C000000246已完成1 期

Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I study - Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer – phase I study(MMTG study)

Multi-modality therapy for gastric cancer study group0 个研究点目标入组 6 人开始时间: 2005年9月22日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Local tumor is not identified by computerized tomography (CT), endoscope or gastrointestinal examination 2)Other severe medical conditions 3)Patients need treatments for bowel obstruction or bleeding 4)Obvious infection or acute inflammatory condition 5)Allergy to drugs containing Cremophor EL (including cyclosporin) 6)Brain metastases with clinical symptom 7)Women who is pregnant, lactating or have the possibility of pregnancy 8)Patients who is judged inappropriate by lead principal investigator

研究者

发起方
Multi-modality therapy for gastric cancer study group

相似试验